Fampridine SR

DRUG6 trials

Sponsors

London Health Sciences Centre, Courtney Casserly, Prof. Dominique de Quervain, MD, University of Basel

Conditions

Cognitive FatigueMild to Moderate DepressionOptic NeuritisPost-covid-19Working Memory

Early Phase 1

Fampridine-SR and Optic Neuritis Recovery

Courtney CasserlyOptic Neuritis

Start: 2022-03-22End: 2024-01-31Target: 20Updated: 2022-08-25

Phase 2

Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?

CompletedNCT01667497

London Health Sciences CentreCognitive Fatigue

Start: 2012-09-30End: 2015-08-31Updated: 2015-09-02

Influence of Fampridine on Working Memory in Healthy Subjects

WithdrawnNCT04516603

Prof. Dominique de Quervain, MDWorking Memory

Start: 2040-01-01End: 2041-12-31Updated: 2024-12-05

Influence of Fampridine on Working Memory in Healthy Young Subjects

CompletedNCT04652557

Prof. Dominique de Quervain, MDWorking Memory

Start: 2021-11-01End: 2023-01-26Updated: 2023-02-06

Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression

RecruitingNCT06751784

University of BaselMild to Moderate Depression, Working Memory

Start: 2025-05-22End: 2026-07-31Target: 38Updated: 2025-12-12

Unknown Phase

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

TerminatedNCT05274477

Prof. Dominique de Quervain, MDPost-covid-19, Working Memory

Start: 2022-06-28End: 2024-06-30Updated: 2024-07-18

Related Papers

The effect of fampridine on working memory: a randomized controlled trial based on a genome-guided repurposing approach

Molecular Psychiatry2024-11-082 citations